Owen W G, Penick G D, Yoder E, Poole B L
Thromb Haemost. 1976 Feb 29;35(1):87-95.
Heparin cofactor, a thrombin inhibitor, is purified from human plasma by affinity chromatography on heparin-agarose. The nature of the binding between thrombin and the inhibitor is studied by treatment of the complex with 6 M guanidinium chloride, hydroxylamine, and dilute alkali. The complex is not dissociated during gel chromatography in 6 M guanidinium chloride. This result supports an earlier proposal that formation of the complex includes the formation of a covalent bond. Treatment of dodecyl sulfate-denatured complex with hydroxylamine results in dissociation of the complex to yield free thrombin and heparin cofactor. Hydroxylamine does not dissociate the complex unless it is denatured. The complex is also dissociated in dilute sodium hydroxide (pH 12) solutions. These results indicate that the covalent bond between thrombin and the inhibitor is a carboxylic ester.
肝素辅因子是一种凝血酶抑制剂,通过在肝素 - 琼脂糖上进行亲和层析从人血浆中纯化得到。通过用6M胍盐酸盐、羟胺和稀碱处理复合物,研究了凝血酶与抑制剂之间结合的性质。在6M胍盐酸盐中进行凝胶层析时,复合物不会解离。这一结果支持了早期的一个观点,即复合物的形成包括共价键的形成。用羟胺处理十二烷基硫酸钠变性的复合物会导致复合物解离,产生游离的凝血酶和肝素辅因子。除非复合物变性,否则羟胺不会使其解离。复合物在稀氢氧化钠(pH 12)溶液中也会解离。这些结果表明,凝血酶与抑制剂之间的共价键是一种羧酸酯。